Literature DB >> 2858443

Immunological cellular regulator and effector mechanisms in myocarditis.

B Maisch, U Bülowius, K Schmier, D Klopf, D Koper, T Sibelis, K Kochsiek.   

Abstract

The diagnosis, pathogenesis and etiology of myocarditis are often difficult to establish with certainty. Consequently, we investigated cellular regulator and effector mechanisms in patients with viral heart disease (Coxsackie B3, influenza, EBV, mumps) as well as other inflammatory heart diseases which could not be classified etiologically. In acute myocarditis there was an elevation of B- and activated T-lymphocytes (OKIa 1-positive) but, in contrast, no significant changes in the activity of peripheral suppressor T-cells (OKT 8-positive). The activity of cell-specific lymphocytic effector mechanisms against vital cardiocytes was unchanged or slightly elevated in myocarditis, while the activity of the less target cell specific natural killer cells, which were measured in vitro against K562 tumor cells, was diminished. These findings are indicative of increased activity of target specific cytotoxic effector mechanisms and a reduction in the activity of nonspecific cellular effector mechanisms in peripheral blood.

Entities:  

Mesh:

Year:  1985        PMID: 2858443

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  8 in total

1.  Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.

Authors:  M Estrin; S A Huber
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

2.  Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.

Authors:  M Estrin; C Smith; S Huber
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

Review 3.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

4.  Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.

Authors:  S A Huber; P A Lodge
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Epstein-Barr virus myocarditis as a cause of sudden death: two autopsy cases.

Authors:  Takaki Ishikawa; Bao-Li Zhu; Dong-Ri Li; Dong Zhao; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2005-04-09       Impact factor: 2.686

6.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.

Authors:  L McLaughlin; G Zhu; M Mistry; C Ley-Ebert; W D Stuart; C J Florio; P A Groen; S A Witt; T R Kimball; D P Witte; J A Harmony; B J Aronow
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Four years of experience in endomyocardial biopsy--an immunohistologic approach.

Authors:  B Maisch; G Büschel; T Izumi; P Eigel; V Regitz; P Deeg; U Pfeifer; A Schmaltz; M Herzum; G Liebau
Journal:  Heart Vessels Suppl       Date:  1985
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.